A phase 3 randomized study of ASP-1929 photoimmunotherapy in combination with pembrolizumab versus standard of care in locoregional recurrent head and neck squamous cell carcinoma (HNSCC).

Authors: Anastasios Maniakas, Ann M. Gillenwater, David Cognetti, Matthew John Mifsud, Noman Ashraf, Francisco F. Civantos, Hassan Danesi, Bogdan Veresh, Shiou-Yi Ethan Chen, Haiying Dong, Cristina Larracas, Susanne M. Arnold

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.tps6122

Source: Full article

---

Abstract

TPS6122